Preferred Label : epoprostenol sodium;
UMLS semantic type : T111 - Eicosanoid; T121 - Pharmacologic Substance;
CAS number : 4K04IQ1OF4;
Is substance : O;
UNII : 4K04IQ1OF4;
InChIKey : LMHIPJMTZHDKEW-XQYLJSSYSA-M;
Origin ID : M0017819;
UMLS CUI : C0354594;
Currated CISMeF NLP mapping
- Related record
- Semantic type(s)
http://www.has-sante.fr/portail/jcms/c_2723461/fr/flolan
2016
false
false
false
France
French
evaluation of the transparency committee
epoprostenol sodium
infusions, intravenous
hypertension, pulmonary
epoprostenol
antihypertensive agents
epoprostenol
---
http://www.has-sante.fr/portail/jcms/c_2611701/fr/flolan
2016
false
France
French
epoprostenol sodium
platelet aggregation inhibitors
epoprostenol
renal dialysis
epoprostenol
infusions, intravenous
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1761605/fr/veletri
http://www.has-sante.fr/portail/jcms/c_1761605/fr/veletri-epoprostenol-prostacycline
2014
false
false
false
France
French
evaluation of the transparency committee
infusions, intravenous
treatment outcome
hypertension, pulmonary
epoprostenol sodium
epoprostenol sodium
epoprostenol
epoprostenol
epoprostenol
antihypertensive agents
antihypertensive agents
renal dialysis
platelet aggregation inhibitors
platelet aggregation inhibitors
emergencies
guidelines for drug use
---
http://www.has-sante.fr/portail/jcms/c_1024128/flolan
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-02/flolan_-_ct-_6424.pdf
2011
false
France
French
epoprostenol sodium
epoprostenol
hypertension, pulmonary
infusions, intravenous
antihypertensive agents
treatment outcome
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_400263
2005
false
France
French
epoprostenol sodium
epoprostenol sodium
epoprostenol
infusions, intravenous
hypertension, pulmonary
collagen diseases
adult
aged
vasodilator agents
antihypertensive agents
treatment outcome
epoprostenol
vasodilator agents
antihypertensive agents
epoprostenol
evaluation of the transparency committee
---
